View Item 

Show simple item record

Pioglitazone protects against thrombosis in a mouse model of obesity and insulin resistance
dc.contributor.authorBodary, Peter F.en_US
dc.contributor.authorVargas, F. B.en_US
dc.contributor.authorKing, S. A. D.en_US
dc.contributor.authorJongeward, K. L.en_US
dc.contributor.authorWickenheiser, K. J.en_US
dc.contributor.authorEitzman, Daniel T.en_US
dc.date.accessioned2010-06-01T18:45:03Z
dc.date.available2010-06-01T18:45:03Z
dc.date.issued2005-10en_US
dc.identifier.citationBODARY, P. F.; VARGAS, F. B.; KING, S. A. D.; JONGEWARD, K. L.; WICKENHEISER, K. J.; EITZMAN, D. T. (2005). "Pioglitazone protects against thrombosis in a mouse model of obesity and insulin resistance." Journal of Thrombosis and Haemostasis 3(10): 2149-2153. <http://hdl.handle.net/2027.42/71948>en_US
dc.identifier.issn1538-7933en_US
dc.identifier.issn1538-7836en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/71948
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=16194192&dopt=citationen_US
dc.format.extent305845 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Science Incen_US
dc.rights2005 International Society on Thrombosis and Haemostasisen_US
dc.subject.otherCoagulationen_US
dc.subject.otherDiabetes Mellitusen_US
dc.subject.otherObesityen_US
dc.subject.otherPlateleten_US
dc.subject.otherSyndrome Xen_US
dc.titlePioglitazone protects against thrombosis in a mouse model of obesity and insulin resistanceen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.identifier.pmid16194192en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/71948/1/j.1538-7836.2005.01551.x.pdf
dc.identifier.doi10.1111/j.1538-7836.2005.01551.xen_US
dc.identifier.sourceJournal of Thrombosis and Haemostasisen_US
dc.identifier.citedreferenceMeigs JB, Mittleman MA, Nathan DM, Tofler GH, Singer DE, Murphy-Sheehy PM, Lipinska I, D'Agostino RB, Wilson PW. Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. JAMA 2000; 283: 221 – 8.en_US
dc.identifier.citedreferenceKannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979; 241: 2035 – 8.en_US
dc.identifier.citedreferenceLebovitz HE. Effects of oral antihyperglycemic agents in modifying macrovascular risk factors in type 2 diabetes. Diabetes Care 1999; 22: C41 – 4.en_US
dc.identifier.citedreferenceBoyne MS, Saudek CD. Effect of insulin therapy on macrovascular risk factors in type 2 diabetes. Diabetes Care 1999; 22: C45 – 53.en_US
dc.identifier.citedreferenceSpiegelman BM. PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. Diabetes 1998; 47: 507 – 14.en_US
dc.identifier.citedreferenceManohar V, Talpur NA, Echard BW, Lieberman S, Preuss HG. Effects of a water-soluble extract of maitake mushroom on circulating glucose/insulin concentrations in KK mice. Diabetes Obes Metab 2002; 4: 43 – 8.en_US
dc.identifier.citedreferenceBodary PF, Westrick RJ, Wickenheiser KJ, Shen Y, Eitzman DT. Effect of leptin on arterial thrombosis following vascular injury in mice. JAMA 2002; 287: 1706 – 9.en_US
dc.identifier.citedreferenceCambien B, Bergmeier W, Saffaripour S, Mitchell HA, Wagner DD. Antithrombotic activity of TNF-alpha. J Clin Invest 2003; 112: 1589 – 96.en_US
dc.identifier.citedreferenceEitzman DT, Bodary PF, Shen Y, Khairallah CG, Wild SR, Abe A, Shaffer-Hartman J, Shayman JA. Fabry disease in mice is associated with age-dependent susceptibility to vascular thrombosis. J Am Soc Nephrol 2003; 14: 298 – 302.en_US
dc.identifier.citedreferenceFuster V, Stein B, Ambrose JA, Badimon L, Badimon JJ, Chesebro JH. Atherosclerotic plaque rupture and thrombosis. Evolving concepts. Circulation 1990; 82: II47 – 59.en_US
dc.identifier.citedreferenceWhite CR, Chang LY, Crapo J, Ku D, Gianturco SH, Gore J, Freeman BA. Superoxide and peroxynitrite in atherosclerosis. Proc Natl Acad Sci 1995; 91: 1044 – 8.en_US
dc.identifier.citedreferenceEitzman DT, Westrick RJ, Xu Z, Tyson J, Ginsburg D. Hyperlipidemia promotes thrombosis after injury to atherosclerotic vessels in apolipoprotein E-Deficient mice. Arterioscler Thromb Vasc Biol 2000; 20: 1831 – 4.en_US
dc.identifier.citedreferenceEitzman DT, Westrick RJ, Nabel EG, Ginsburg D. Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice. Blood 2000; 95: 577 – 80.en_US
dc.identifier.citedreferenceHe L, Vicente CP, Westrick RJ, Eitzman DT, Tollefsen DM. Heparin cofactor II inhibits arterial thrombosis after endothelial injury. J Clin Invest 2002; 109: 213 – 9.en_US
dc.identifier.citedreferenceWestrick RJ, Bodary PF, Xu Z, Shen YC, Broze GJ, Eitzman DT. Deficiency of tissue factor pathway inhibitor promotes atherosclerosis and thrombosis in mice. Circulation 2001; 103: 3044 – 6.en_US
dc.identifier.citedreferenceSuto J, Matsuura S, Imamura K, Yamanaka H, Sekikawa K. Genetic analysis of non-insulin-dependent diabetes mellitus in KK and KK-Ay mice. Eur J Endocrinol 1998; 139: 654 – 61.en_US
dc.identifier.citedreferenceFerroni P, Basili S, Falco A, Davi G. Platelet activation in type 2 diabetes mellitus. J Thromb Haemost 2004; 2: 1282 – 91.en_US
dc.identifier.citedreferenceAndre P, Hartwell D, Hrachovinova I, Saffaripour S, Wagner DD. Pro-coagulant state resulting from high levels of soluble P-selectin in blood. Proc Natl Acad Sci U S A 2000; 97: 13835 – 40.en_US
dc.identifier.citedreferenceAkbiyik F, Ray DM, Gettings KF, Blumberg N, Francis CW, Phipps RP. Human bone marrow megakaryocytes and platelets express PPARgamma, and PPARgamma agonists blunt platelet release of CD40 ligand and thromboxanes. Blood 2004; 104: 1361 – 8.en_US
dc.identifier.citedreferenceSidhu JS, Cowan D, Tooze JA, Kaski JC. Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reduces circulating platelet activity in patients without diabetes mellitus who have coronary artery disease. Am Heart J 2004; 147: 1032 – 7.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1538-7836.2005.01551.x.pdf
Size:
298.6KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.